Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$26.4 - $32.56 $42,662 - $52,616
1,616 New
1,616 $43,000
Q3 2023

Nov 07, 2023

SELL
$27.17 - $31.97 $291,615 - $343,134
-10,733 Reduced 58.65%
7,567 $211,000
Q2 2023

Aug 08, 2023

BUY
$28.34 - $33.63 $518,622 - $615,429
18,300 New
18,300 $572,000
Q4 2022

Feb 13, 2023

BUY
$21.94 - $26.24 $428,554 - $512,545
19,533 Added 813.88%
21,933 $573,000
Q3 2022

Nov 07, 2022

BUY
$22.0 - $31.87 $52,800 - $76,488
2,400 New
2,400 $53,000
Q1 2022

May 16, 2022

SELL
$23.07 - $27.99 $46,416 - $56,315
-2,012 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$21.47 - $32.08 $9,382 - $14,018
-437 Reduced 17.84%
2,012 $46,000
Q3 2021

Nov 09, 2021

SELL
$23.37 - $32.13 $192,615 - $264,815
-8,242 Reduced 77.09%
2,449 $75,000
Q2 2021

Aug 12, 2021

BUY
$18.78 - $25.15 $200,363 - $268,325
10,669 Added 48495.45%
10,691 $262,000
Q1 2021

May 14, 2021

BUY
$18.21 - $23.2 $400 - $510
22 New
22 $0
Q3 2020

Nov 16, 2020

SELL
$16.16 - $20.66 $7,449 - $9,524
-461 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$13.31 - $19.41 $6,135 - $8,948
461 New
461 $8,000
Q1 2020

May 13, 2020

SELL
$13.06 - $21.24 $250,529 - $407,446
-19,183 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$17.29 - $21.74 $293,636 - $369,210
16,983 Added 771.95%
19,183 $391,000
Q3 2019

Nov 12, 2019

SELL
$19.51 - $24.28 $37,069 - $46,132
-1,900 Reduced 46.34%
2,200 $42,000
Q2 2019

Aug 13, 2019

BUY
$21.47 - $37.33 $57,969 - $100,791
2,700 Added 192.86%
4,100 $92,000
Q1 2019

May 13, 2019

BUY
$28.4 - $36.49 $2,840 - $3,649
100 Added 7.69%
1,400 $51,000
Q4 2018

Feb 13, 2019

SELL
$27.94 - $44.61 $239,334 - $382,129
-8,566 Reduced 86.82%
1,300 $38,000
Q3 2018

Nov 13, 2018

BUY
$38.6 - $46.12 $380,827 - $455,019
9,866 New
9,866 $418,000
Q4 2017

Feb 12, 2018

SELL
$47.69 - $55.39 $118,748 - $137,921
-2,490 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$49.16 - $54.45 $122,408 - $135,580
2,490
2,490 $126,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.